WallStreetZenWallStreetZen

NASDAQ: CDT
Conduit Pharmaceuticals Inc Stock

$2.59+0.02 (+0.78%)
Updated Mar 1, 2024
CDT Price
$2.59
Fair Value Price
-$0.02
Market Cap
$188.59M
52 Week Low
$0.95
52 Week High
$25.00
P/E
0x
P/B
-174.46x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$7.41M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-12.12
Operating Cash Flow
-$4M
Beta
0.19
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CDT Overview

Murphy Canyon Acquisition Corporation is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the construction/homebuilding companies and adjacent businesses targeting the real estate space. Murphy Canyon Acquisition was incorporated in 2021 and is headquartered in San Diego, CA.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CDT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CDT ($2.59) is overvalued by 11,470.23% relative to our estimate of its Fair Value price of -$0.02 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CDT ($2.59) is not significantly undervalued (11,470.23%) relative to our estimate of its Fair Value price of -$0.02 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CDT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CDT due diligence checks available for Premium users.

Be the first to know about important CDT news, forecast changes, insider trades & much more!

CDT News

Valuation

CDT fair value

Fair Value of CDT stock based on Discounted Cash Flow (DCF)
Price
$2.59
Fair Value
-$0.02
Undervalued by
11,470.23%
CDT ($2.59) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CDT ($2.59) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CDT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CDT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
0x
Industry
15.19x
Market
36.17x

CDT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-174.46x
Industry
6.18x

CDT's financial health

Profit margin

Revenue
$0.0
Net Income
$2.0M
Profit Margin
0%
CDT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$12.0M
Liabilities
$13.1M
Debt to equity
-12.12
CDT's short-term assets ($10.44M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CDT's short-term assets ($10.44M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CDT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CDT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$524.0k
Investing
$560.0k
Financing
$8.6M
CDT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CDT vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CDT$188.59M+0.78%-0.00x-174.46x
VXRT$190.05M+2.46%-1.95x2.66x
TRVI$187.10M+0.34%-13.32x2.09x
NVCT$185.39M+8.41%-7.13x11.11x
GRTS$192.59M-27.86%-1.63x2.60x

Conduit Pharmaceuticals Stock FAQ

What is Conduit Pharmaceuticals's quote symbol?

(NASDAQ: CDT) Conduit Pharmaceuticals trades on the NASDAQ under the ticker symbol CDT. Conduit Pharmaceuticals stock quotes can also be displayed as NASDAQ: CDT.

If you're new to stock investing, here's how to buy Conduit Pharmaceuticals stock.

What is the 52 week high and low for Conduit Pharmaceuticals (NASDAQ: CDT)?

(NASDAQ: CDT) Conduit Pharmaceuticals's 52-week high was $25.00, and its 52-week low was $0.95. It is currently -89.64% from its 52-week high and 172.63% from its 52-week low.

How much is Conduit Pharmaceuticals stock worth today?

(NASDAQ: CDT) Conduit Pharmaceuticals currently has 72,813,776 outstanding shares. With Conduit Pharmaceuticals stock trading at $2.59 per share, the total value of Conduit Pharmaceuticals stock (market capitalization) is $188.59M.

Conduit Pharmaceuticals stock was originally listed at a price of $10.03 in Feb 3, 2022. If you had invested in Conduit Pharmaceuticals stock at $10.03, your return over the last 2 years would have been -74.18%, for an annualized return of -49.18% (not including any dividends or dividend reinvestments).

How much is Conduit Pharmaceuticals's stock price per share?

(NASDAQ: CDT) Conduit Pharmaceuticals stock price per share is $2.59 today (as of Mar 1, 2024).

What is Conduit Pharmaceuticals's Market Cap?

(NASDAQ: CDT) Conduit Pharmaceuticals's market cap is $188.59M, as of Mar 3, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Conduit Pharmaceuticals's market cap is calculated by multiplying CDT's current stock price of $2.59 by CDT's total outstanding shares of 72,813,776.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.